Simplify Logo

Full-Time

Principal Platform Architect

Confirmed live in the last 24 hours

Karius

Karius

51-200 employees

Non-invasive diagnostic tests for infections

Data & Analytics
Consulting
Hardware
AI & Machine Learning
Financial Services
Biotechnology
Healthcare

Compensation Overview

$210k - $290kAnnually

Senior, Expert

San Carlos, CA, USA

Category
DevOps & Infrastructure
Platform Engineering
Required Skills
Kubernetes
Digital Ocean
Docker
Terraform
Development Operations (DevOps)
Data Analysis
Requirements
  • B.S. or M.S. in Computer Science, Electrical Engineering, Physics, Statistics, Biomedical Engineering, Genetics, or a related engineering or science field. Ph.D. in these fields is a big plus.
  • 15+ years of engineering experience, 10 of which in leading the development and operation of distributed software systems and cloud-native platforms.
  • Proficient in infrastructure-as-code design and tools such as Terraform.
  • Deep knowledge and experience in design patterns, implementation, testing, and failure management of distributed systems and microservices.
  • Hands-on experience with cloud-native software development and operations approach; primarily using tools and technologies such as Docker, Kubernetes, and Cloud services to run software services and data analytics jobs.
  • Proficient in industry security standards such as NIST CSF/SSDF with hands-on experience implementing and monitoring cloud security controls.
  • Experience with various code flow and DevOps approaches such as gitOps.
  • Experience in healthcare and life sciences especially developing medical devices is a big plus.
Responsibilities
  • Leading architectural projects from concept to completion, ensuring timely delivery and adherence to budget and quality/regulatory requirements.
  • Developing architectural blueprints, frameworks, and guidelines for Platform development and operation.
  • Ensuring the architecture meets technical and business requirements including security, performance, interoperability, and scalability.
  • Staying current with industry trends and emerging technologies to ensure the Platform leverages the best technologies that fit the needs.
  • Articulating and presenting complex ideas clearly and effectively to technical and business audiences.
  • Developing, documenting, and organizing artifacts such as strategy, technical proposals and designs, and risk assessments.
  • Ensuring Karius’s R&D and engineering staff have the proper infrastructure, tools, and processes to be productive.
  • Ensuring the Karius Platform is cloud vendor agnostic, can be provisioned globally using a blueprint as code, and meets regional privacy and security rules and regulations.
  • Enable the Platform to be provisioned for non-Karius laboratories, enabling them to operate Karius products.

Karius focuses on medical diagnostics for infectious diseases, offering the Karius Test, a liquid biopsy that detects over 1,000 pathogens from a single blood sample. This non-invasive test is quick and helps clinicians treat hospitalized patients by reducing the need for multiple invasive tests that can delay treatment. The Karius Test utilizes advanced genomics and artificial intelligence to identify microbial cell-free DNA (mcfDNA) in the bloodstream, providing insights into the pathogens responsible for infections. Karius differentiates itself from competitors by offering a faster, non-invasive alternative to traditional diagnostic methods, which can save lives and lower healthcare costs. The company's goal is to enhance infectious disease diagnostics through continuous learning and improvement of their machine learning algorithms and genomic databases.

Company Stage

Series C

Total Funding

$345M

Headquarters

Redwood City, California

Founded

2014

Growth & Insights
Headcount

6 month growth

16%

1 year growth

13%

2 year growth

11%
Simplify Jobs

Simplify's Take

What believers are saying

  • Securing $100M in Series C funding from prominent investors like Khosla Ventures and 5AM Ventures positions Karius for significant expansion and technological advancement.
  • The Karius Test's ability to detect a wide range of pathogens quickly can lead to faster treatment decisions, potentially saving lives and reducing healthcare costs.
  • The addition of experienced board members, including those from Khosla Ventures and Gilde Healthcare, brings valuable expertise and strategic guidance to the company.

What critics are saying

  • The high cost of advanced genomic diagnostics may limit widespread adoption, particularly in resource-constrained healthcare settings.
  • The competitive landscape in medical diagnostics is intense, with numerous companies vying for market share, which could impact Karius's growth.

What makes Karius unique

  • Karius leverages advanced genomics and AI to detect over 1,000 pathogens from a single blood sample, offering a non-invasive and rapid diagnostic alternative unlike traditional methods.
  • The continuous updating of their reference genome databases ensures that Karius stays at the forefront of infectious disease diagnostics, providing real-time insights.
  • The FDA Breakthrough Device designation for the Karius Test underscores its innovative approach and potential impact on the diagnosis and management of infectious diseases in immunocompromised patients.